Phase II trial of graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide after reduced-intensity busulfan/fludarabine conditioning for hematological malignancies

Amin M. Alousi, Jonathan E. Brammer, Rima M. Saliba, Borje Andersson, Uday Popat, Chitra Hosing, Roy Jones, Elizabeth J. Shpall, Issa Khouri, Muzaffar Qazilbash, Yago Nieto, Nina Shah, Sairah Ahmed, Betul Oran, Gheath Al Atrash, Stefan Ciurea, Partow Kebriaei, Julianne Chen, Gabriela Rondon, Richard E. Champlin

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide after reduced-intensity busulfan/fludarabine conditioning for hematological malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences